Cleared Traditional

K780018 - THYRO-INDICATOR T-3 125I

K780018 is an FDA 510(k) clearance for THYRO-INDICATOR T-3 125I, manufactured by Clinical Immuno-Diagnostics. The device is a Class 2 Immunology device with product code CDP cleared through the Traditional 510(k) pathway after a 35-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1978
Decision
35d
Days
Class 2
Risk

K780018 is an FDA 510(k) clearance for the THYRO-INDICATOR T-3 125I. Classified as Radioimmunoassay, Total Triiodothyronine (product code CDP), Class II - Special Controls.

Submitted by Clinical Immuno-Diagnostics (Mchenry, US). The FDA issued a Cleared decision on February 7, 1978 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1710 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K780018

510(k) Number K780018 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 1978
Decision Date February 07, 1978
Days to Decision 35 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 105d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CDP Device Classification - Class 2, Special Controls

Product Code CDP Radioimmunoassay, Total Triiodothyronine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1710
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CDP Radioimmunoassay, Total Triiodothyronine

All 143
Devices cleared under the same product code (CDP) and FDA review panel - the closest regulatory comparables to K780018.
CBR-T3RIA KIT
K780499 · Clinical Bioresearch · May 1978
GAMMA STIK 125I T3 UPTAKE KIT
K780492 · Alpha Gamma Laboratory · Apr 1978
TRIA-PEG RIA DIAG. KIT
K780292 · Nuclear Diagnostics, Inc. · Mar 1978
TRI-TAB-RIA
K772177 · Nuclear Medical Laboratories, Inc. · Dec 1977
IN VITRO T3 RIA TEST
K772108 · Clinical Assays, Inc. · Nov 1977
T3 RIA KIT
K772122 · Antibodies, Inc. · Nov 1977